Rani Khatib

Profile

Dr Rani Khatib is the National Specialty Advisor for Cardiovascular Disease Prevention at NHS England and a Fellow of the European Society of Cardiology. 

Dr Khatib belongs to the Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM), Faculty of Medicine and Health. A Visiting Associate Professor with a wealth of teaching and research experience contributing to the education of physicians, pharmacists, nurses, midwives and other healthcare professionals at undergraduate and postgraduate level.

As a senior clinician at Leeds Teaching Hospitals NHS Trust, he is a Consultant Pharmacist in Cardiology and Cardiovascular Research. Clinical Lead of the Innovative CardioRenalMetabolic Meds Opt group at the Cardiology Department. Leads the cardiology medicines and risk optimisation agenda across the secondary and primary care pathways in Leeds. He is an independent prescriber with direct patient responsibility. 

He leads on the delivery of the following multidisciplinary medicines optimisation services:

• Cardiometabolic Post MI Clinics 
• Advanced Cardiology Medicines Optimison Clinic
• Post Myocardial Infarction Medicines Optimisation Clinics
• Innovative Medicines Clinic - PCSK9 Inhibitors and statin intolerance
• Heart Failure Virtual Medicines Optimisation Clinic

Well published, holds several research grants, principal investigator and co-investigator of several trials with specific interest in medicine adherence and the optimisation of medicines and risk in cardiology.

Lead author of the NICE endorsed, NHS England national lipids management and statin intolerance pathways. 

• NHS Accelerated Access Collaborative » Summary of national guidance for lipid management
• NHS Accelerated Access Collaborative » Statin intolerance pathway

Lead author and developer of the MYMEDS tool, for assessing medicines adherence barriers among patients with post-myocardial infarction. 

• The my experience of taking medicines (MYMEDS) questionnaire for assessing medicines adherence barriers in post-myocardial infarction patients: development and utility | BMC Cardiovascular Disorders | Full Text

Professional Bodies Membership and Roles

• National Specialty Advisor for CVD Prevention, NHS England
• Board of the ESC Council on Hypertension ¦European Society of Cardiology
• Heart Failure Expert Advisory Group, NHS Engalnd
• National Clinical Champion for PCSK9i and Lipid Management, Accelerated Access Collaborative, NHS England. 
• NICE Heart Failure Guideline & Quality Standards (2023)
• Fellow of the European Society of Cardiology
• Fellow of Royal Pharmaceutical Society
• Past chair of the UK Clinical Pharmacy Association, Cardiology Group. 
• Member of the Science Committee at the European Society of Cardiology - ACNAP
• Member of the Cardiology Allied Professionals Task Force at the European Society of Cardiology. 

Earned multiple recognitions and awards for innovation and excellence in patient care. 

Research interests

• CVD Prevention
• CardioRenalMetabolic
• Hypercholesterolaemia
• Medicines Adherence
• Medicines Optimisation
• Post Myocardial Infarction Medicines Optimisation
• Patient Centred Practice
• Heart Failure
• PCSK9 inhibitors & lipid management 
• Cardiometabolic medicines and risk optimisation
• Anticoagulants
• Hypertension 
• Atrial Fibrillation 

Professional memberships

• European Society of Cardiology
• General Pharmaceutical Council
• Royal Pharmaceutical Society
• UK Clinical Pharmacy Association

Research groups and institutes

• Leeds Institute of Cardiovascular and Metabolic Medicine